RETRACTED: Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans (Retracted article. See vol. 175, pg. 1992, 2018)

被引:112
作者
Murthy, KHM
Smith, SA
Ganesh, VK
Judge, KW
Mullin, N
Barlow, PN
Ogata, CM
Kotwal, GJ
机构
[1] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA
[2] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA
[3] Univ Edinburgh, Edinburgh Ctr Prot Technol, Edinburgh EH9 3JJ, Midlothian, Scotland
[4] Brookhaven Natl Lab, Howard Hughes Med Inst, Upton, NY 11973 USA
关键词
D O I
10.1016/S0092-8674(01)00214-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vaccinia virus complement control protein (VCP) inhibits both pathways of complement activation through binding the third and fourth components. A homolog of mammalian regulators of complement activation, its ability to bind heparin endows VCP with additional activities of significance to viral infectivity. The structure of VCP reveals a highly extended molecule with a putative heparin recognition site at its C-terminal end. A second duster of positive charges provides a possibly overlapping binding site for both heparin and complement components. Experiments suggested by the structure indicate that VCP can bind heparin and control complement simultaneously. This, the structure of any intact regulator of complement activation, along with attendant functional insights, will stimulate the design of new therapeutic inhibitors of complement.
引用
收藏
页码:301 / 311
页数:11
相关论文
共 62 条
[21]  
HENDERSON CE, 2000, IN PRESS J MOL BIOL
[22]   DETERMINATION OF MACROMOLECULAR STRUCTURES FROM ANOMALOUS DIFFRACTION OF SYNCHROTRON RADIATION [J].
HENDRICKSON, WA .
SCIENCE, 1991, 254 (5028) :51-58
[23]  
HESSING M, 1990, J IMMUNOL, V144, P204
[24]  
HILLARP A, 1988, J BIOL CHEM, V263, P12759
[25]   Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat [J].
Howard, J ;
Justus, DE ;
Totmenin, AV ;
Shchelkunov, S ;
Kotwal, GJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (01) :68-71
[26]  
Hughes-Jones Nevin C, 1986, IMMUNOBIOLOGY COMPLE, P21
[27]   VACCINIA VIRUS COMPLEMENT-CONTROL PROTEIN PREVENTS ANTIBODY-DEPENDENT COMPLEMENT-ENHANCED NEUTRALIZATION OF INFECTIVITY AND CONTRIBUTES TO VIRULENCE [J].
ISAACS, SN ;
KOTWAL, GJ ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :628-632
[28]   IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS [J].
JONES, TA ;
ZOU, JY ;
COWAN, SW ;
KJELDGAARD, M .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :110-119
[29]   Central modules of the vaccinia virus complement control protein are not in extensive contact [J].
Kirkitadze, MD ;
Henderson, C ;
Price, NC ;
Kelly, SM ;
Mullin, NP ;
Parkinson, J ;
Dryden, DTF ;
Barlow, PN .
BIOCHEMICAL JOURNAL, 1999, 344 :167-175
[30]  
Kotwal G J, 1994, Am Biotechnol Lab, V12, P76